Peter L. Hoang
Director/Board Member chez Esperance Pharmaceuticals, Inc.
Fortune : 143 001 $ au 31/03/2024
Profil
Peter L.
Hoang currently works at Esperance Pharmaceuticals, Inc., as Director.
Mr. Hoang also formerly worked at Marker Therapeutics, Inc., as President, Chief Executive Officer & Director from 2017 to 2023, Tapimmune, Inc., as President & Chief Executive Officer, Oppenheimer & Co., Inc., as Executive Director-Global Mergers & Acquisitions, The University of Texas M.D.
Anderson Cancer Center, as Managing Director-Innovations from 2012 to 2014, CIT Group, Inc., as MD, Head-Healthcare Mergers & Acquisitions from 2010 to 2012, JPMorgan Chase & Co., as Head-Mergers & Acquisitions, Bellicum Pharmaceuticals, Inc., as Senior VP-Business Development & Strategy from 2014 to 2017, Deutsche Bank Corp., as Head-Mergers & Acquisitions, and Merrill Lynch & Co., Inc., as Head-Mergers & Acquisitions.
Mr. Hoang received his undergraduate degree from Yale University and Masters Business Admin degree from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2023 | 33 256 ( 0,37% ) | 143 001 $ | 31/03/2024 |
Postes actifs de Peter L. Hoang
| Sociétés | Poste | Début |
|---|---|---|
Esperance Pharmaceuticals, Inc.
 Esperance Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Esperance Pharmaceuticals, Inc. develops oncology products. It specializes in oncology products that selectively kill cancer cells without harming normal cells. The company was founded by Hector W. Alila in 2006 and is headquartered in Baton Rouge, LA. | Director/Board Member | - |
Anciens postes connus de Peter L. Hoang
| Sociétés | Poste | Fin |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Chief Executive Officer | 01/05/2023 |
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2017 |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01/11/2014 |
| CIT GROUP INC. | Corporate Officer/Principal | 01/03/2012 |
| Tapimmune, Inc. | Chief Executive Officer | - |
Formation de Peter L. Hoang
| Yale University | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| JPMORGAN CHASE & CO. | Finance |
| Entreprise privées | 8 |
|---|---|
CIT Group, Inc.
 CIT Group, Inc. Major BanksFinance CIT Group, Inc. is a financial holding company, which engages in the financing, leasing and advisory services. It operates through the following business segments: Commercial Banking, Consumer Banking, and Corporate. The Commercial Banking segment consists of four divisions, commercial finance, rail, and real estate finance and business capital. The Consumer Banking segment includes retail Banking, consumer lending, and SBA lending, which are grouped together for purposes of discussion as other consumer banking and legacy consumer mortgages. The Corporate segment refers to the businesses and portfolios that they no longer consider strategic. These portfolios include equipment financing, secured lending and leasing and advisory services to small and middle-market businesses. The company was founded by Henry Ittelson in 1908 and is headquartered in New York, NY. | Finance |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Deutsche Bank Corp.
 Deutsche Bank Corp. Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank Corp. is a private company based in New York, NY. | Finance |
Esperance Pharmaceuticals, Inc.
Esperance Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Esperance Pharmaceuticals, Inc. develops oncology products. It specializes in oncology products that selectively kill cancer cells without harming normal cells. The company was founded by Hector W. Alila in 2006 and is headquartered in Baton Rouge, LA. | Health Technology |
| Merrill Lynch & Co., Inc. | Finance |
| Tapimmune, Inc. |
